Analysis of Effectiveness and Safety of Teclistamab in Relapsed and Refractory Multiple Myeloma Patients
Clinical trial NCT06062537 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06062537
- Sponsor
- Intergroupe Francophone du Myelome
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-09-19
- Primary completion
- 2026-12-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.